"Designing Growth Strategies is in our DNA"

Anti-Inflammatory Biologics Market Size, Share & Industry Analysis, By Drug Class (Anti-Tumor Necrosis Factor (TNF), Interleukin Antagonists, Janus Kinase (JAK) Inhibitors, Others), By Application (Rheumatoid Arthritis, Psoriasis, and Others), By Route of Administration (Oral and Injection (Subcutaneous and Intravenous)), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027

The global anti-inflammatory biologics market size was valued at USD 64.84 billion in 2019 and is projected to reach USD 149.80 billion by 2027, exhibiting a CAGR of 11.0... Read More

Final report will be updated to address the impact of COVID-19 on this particular market

Region : Global | Published Date: May, 2020 | Report ID: FBI102733 | Status : Published

 

Request Sample

Refresh Button
Anti-Inflammatory Biologics Market Size, Share and Global Industry Trend Forecast till 2025
  • PDF
  • 2019
  • 2016-2018
  • 145
  • Direct Purchase
  • 4850
    6850
    8850

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver


We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X